mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.009 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.009 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.009 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.01 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |